Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978871 · ClinicalTrials.gov registry record · NA
Effect of Emotion Mindsets on Emotion Processing
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT03978871: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT03978871 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 163 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03978871, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
The guiding scientific premise for this research is that a growth emotion mindset will promote more adaptive emotion processing than a fixed emotion mindset. Because emotional sensitivity is particularly salient in adolescent girls, we will focus on this group. Using an experimental design, adolescent girls will be randomly assigned to either a mindset manipulation or a control group (brain education). Each group will complete a 25-minute computer-based lesson followed by a social stressor and a functional magnetic resonance imaging session. Two specific aims will be addressed: (1) to determine whether a growth mindset induction, relative to a control condition, predicts more adaptive emotion processing at the neural, behavioral, and psychological levels of processing; and (2) to determine whether neural processing of emotion accounts for the effect of a growth emotion mindset manipulation on behavioral and psychological processing of emotion. This study builds on a strong empirical database establishing the effect of mindsets on multiple domains of functioning but will be the first to examine the implications of a growth vs. fixed mindset about emotion for emotion processing in adolescent girls, thereby elucidating one specific youth attribute that can support or disrupt emotional development.
Primary Outcome
Participants completed a six-item fixed emotion mindset measure (EMS-fixed) measure, prior to (pre-induction EMS) and following the induction lessons (post-induction EMS). Items were drawn from the Implicit Theories of Emotion Scale (Tamir et al., 2007) and the Emotion Mindset Scale (EMS; Livingstone, 2013). Participants rated each item on a 6-point scale (1 = Strongly Disagree to 6 =Strongly Agree). Means were computed for these items, with higher scores representing a higher fixed emotion mind
Interventions
- BEHAVIORAL Growth Mindset
- BEHAVIORAL Brain Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
What the finished NCT03978871 record still lists
NCT03978871 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Growth Mindset is the first listed.
NCT03978871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03978871 about?
NCT03978871 is a clinical study titled "Effect of Emotion Mindsets on Emotion Processing". The guiding scientific premise for this research is that a growth emotion mindset will promote more adaptive emotion processing than a fixed emotion mindset. Because emotional sensitivity is particularly salient in adolescent girls, we will focus on this group. Using an experimental design, adolesce...
What is the current status of trial NCT03978871?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2018-08-27. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03978871?
The interventions under investigation include: Growth Mindset (BEHAVIORAL), Brain Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03978871?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03978871's enrollment target sits among peer trials
163 627th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI